That is how I think too. Many are concerned about the 'silence' on the PR front, but I'd like to think that Missling is being methodical working his plan in the patients and shareholders interest, not least his own, and 'without fear'.
Then click on "Assignments" tab. Then look in the upper right corner of the page and you see the issue date of the patent.
9/5/17
We should get an PR on either 9/5 or 9/6. I'd guess 9/5.
Going to be a huge 4-day week!!!
What I do not get is.... why do only stalk? Have concluded that the FDA and US Govt.(read politicians) are involved w/studies and are watching every move very closely.
I'm not saying that a well constructed BO deal would be bad, especially if we get shares of the acquiring BP (i.e. future growth). I would imagine that Skarpelos and Missling have a plan and know what they're doing. Even if a BO became hostile, the valuation would be generous given the shareholder rights plan (poison pill). I'll accept whatever happens...